Cargando…

Review of Bone Modifying Agents in Metastatic Breast Cancer

Bone is the most common site for distant metastases in breast cancer and can cause significant morbidity and mortality. Bone modifying agents (BMAs) that include bisphosphonates (BPAs) and denosumab help in decreasing and delaying skeletal-related events (SREs) associated with metastatic breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raghu Subramanian, Charumathi, Talluri, Swapna, Mullangi, Sanjana, Lekkala, Manidhar R, Moftakhar, Bahar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960030/ https://www.ncbi.nlm.nih.gov/pubmed/33738175 http://dx.doi.org/10.7759/cureus.13332

Ejemplares similares

Incidental Finding of Squamous Cell Carcinoma on a 68Ga-DOTATATE PET Scan
por: Mullangi, Sanjana, et al.
Publicado: (2021)

A Case of De Novo Psoriasis Secondary to Nivolumab in a Patient With Metastatic Renal Cell Carcinoma
por: Mullangi, Sanjana, et al.
Publicado: (2021)

New-Onset Autoimmune Diabetes Mellitus Presenting As Diabetic Ketoacidosis in Association With Pembrolizumab Therapy and Long Term Follow-Up: Case Report
por: Pachpande, Vrushali, et al.
Publicado: (2022)

Protecting High-Risk Oncology Patients During the COVID-19 Pandemic by Creating an Isolated Outpatient Clinic
por: Abedi, Seyed Mohammad, et al.
Publicado: (2022)

Isolated Left Ventricular Metastasis from Renal Cell Carcinoma: Diagnostic and Therapeutic Dilemma
por: Abdullah, Amirahwaty, et al.
Publicado: (2018)

Atypical presentation of central pontine myelinolysis in hyperglycemia
por: Talluri, Swapna, et al.
Publicado: (2017)

Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients With Multiple Comorbidities: Long-Term Safety and Efficacy Results From a Tertiary Care Community Hospital
por: Raghu Subramanian, Charumathi, et al.
Publicado: (2020)

Temporal Trends, Predictors, and Outcomes of Disseminated Intravascular Coagulation in Hospitalizations With Sepsis
por: Solanki, Dhanshree, et al.
Publicado: (2022)

Epidemiology and Outcomes of Hospitalizations Due to Hepatocellular Carcinoma
por: Mullangi, Sanjana, et al.
Publicado: (2021)

MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting Mitochondria and Eradicating Cancer Stem Cells (CSCs), With Anti-Tumor and Anti-Metastatic Activity In Vivo
por: Sargiacomo, Camillo, et al.
Publicado: (2021)

Association of Women Authors With Women Enrollment in Clinical Trials of Atrial Fibrillation
por: Khan, Safi U., et al.
Publicado: (2022)

Manipulating RKIP reverses the metastatic potential of breast cancer cells
por: Lai, Trang Huyen, et al.
Publicado: (2023)

Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials
por: Schreiber, Anna R., et al.
Publicado: (2021)

Surgical Management of Metastatic Breast Cancer: A Mini Review
por: Ueno, Takayuki
Publicado: (2022)

Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach
por: Fabi, Alessandra, et al.
Publicado: (2022)

Refractory gastroesophageal reflux disease
por: Subramanian, Charumathi Raghu, et al.
Publicado: (2015)

Care of inflammatory bowel disease patients in remission
por: Raghu Subramanian, Charumathi, et al.
Publicado: (2016)

A systemic review of taxanes and their side effects in metastatic breast cancer
por: Lai, Jiun-I., et al.
Publicado: (2022)

Medicago Sativa Defensin1 as a tumor sensitizer for improving chemotherapy: translation from anti-fungal agent to a potential anti-cancer agent
por: Pandurangi, Raghu, et al.
Publicado: (2023)

Pseudoprogression after advanced first-line endocrine therapy in metastatic breast cancer with bone metastasis: A case report
por: Tian, Aijuan, et al.
Publicado: (2023)

Breast cancer metastatic to the kidney: Case report
por: Ahmed, Yacoub, et al.
Publicado: (2020)

Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study
por: Jiang, Xiaofan, et al.
Publicado: (2022)

Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer
por: Chung, Ivy, et al.
Publicado: (2021)

Efficacy and Safety of Anti-HER2 Agents in Combination With Chemotherapy for Metastatic HER2-Positive Breast Cancer Patient: A Network Meta-Analysis
por: Zhang, Xiaohui, et al.
Publicado: (2021)

Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer
por: Husinka, Lakyn, et al.
Publicado: (2020)

Case Report: Small intestinal metastatic breast cancer: A case report and literature review
por: Li, Yishan, et al.
Publicado: (2022)

Osteoid cell-derived chemokines drive bone-metastatic prostate cancer
por: Johnson, Catherine S., et al.
Publicado: (2023)

Systemic adverse effects and toxicities associated with immunotherapy: A review
por: Kichloo, Asim, et al.
Publicado: (2021)

Effect of the COVID-19 pandemic on use of bone-modifying agents for metastatic breast cancer in a UK Oncology centre
por: Wang, L., et al.
Publicado: (2020)

Bone-Modifying Agents in Early-Stage and Advanced Breast Cancer
por: Heeke, Arielle, et al.
Publicado: (2018)

Case Report: Immune Checkpoint Inhibitors as a Single Agent in the Treatment of Metastatic Cervical Cancer
por: Anipindi, Manasa, et al.
Publicado: (2022)

Berberine as a potential agent for breast cancer therapy
por: Zhong, Xiao-Dan, et al.
Publicado: (2022)

Bone Marrow Adipocytes, Adipocytokines, and Breast Cancer Cells: Novel Implications in Bone Metastasis of Breast Cancer
por: Liu, Chang, et al.
Publicado: (2020)

Ureteropelvic Junction Obstruction Secondary to Metastatic Relapse of Breast Cancer
por: Shah, Paras H., et al.
Publicado: (2015)

Differences in Tumor Immune Microenvironment in Metastatic Sites of Breast Cancer
por: Lee, Hyunjong, et al.
Publicado: (2021)

Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer
por: Ibrahim, Nuhad K.
Publicado: (2021)

Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer
por: Harry, Jordan A., et al.
Publicado: (2021)

ESR1 fusions and therapeutic resistance in metastatic breast cancer
por: Nagy, Zsuzsanna, et al.
Publicado: (2023)

Oncolytic virotherapy for metastatic breast cancer – a case report
por: Gesundheit, Benjamin, et al.
Publicado: (2023)

Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients
por: Tao, Zhonghua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jej22klqnunlov726hu3heuh4c